Episode Summary
Executive Summary: Sam Harris and Roland Griffiths discuss the rapid maturation of psychedelic science, the risks of premature cultural legalization, and the distinct roles of medical approval, meditation, and secular spirituality. Griffiths also reflects on his stage-four cancer diagnosis, describing how it intensified gratitude, acceptance, and inquiry into mortality, while motivating an endowment to support perpetual empirical research at Johns Hopkins.
Main Topics: State of psychedelic research and regulation: Griffiths describes the surge in academic, NIH, and commercial interest in psychedelics, including MDMA and psilocybin trials, while noting that FDA approval remains uncertain and state-level legalization creates unresolved federal conflicts. Risks, screening, and set/setting: Both speakers stress that psychedelics can be dangerous in vulnerable populations, especially for people with personal or family histories of psychosis or bipolar disorder, and that poor context can lead to panic, disorientation, or harmful behavior. Psychedelics, meditation, and consciousness: The conversation compares psychedelics and meditation as complementary tools for investigating mind, with Griffiths arguing that both can reduce identification with thought, increase awareness of interconnectedness, and support awakening-like experiences. Healthy users, well-being, and secular spirituality: Beyond clinical indications, Griffiths emphasizes the larger promise of psychedelics for psychologically healthy people seeking meaning, gratitude, and ethical transformation, framed as 'secular spirituality' rather than religion or paranormal belief. Cancer diagnosis and mortality: Griffiths recounts discovering stage-four colon cancer with liver metastases, his emotional progression from disbelief to gratitude, and how meditation and psychedelics helped him meet illness and death with equanimity. Endowment for perpetual research: Griffiths explains his plan to endow a Johns Hopkins professorship and research program focused on psychedelic research, well-being, and spirituality, aiming to secure long-term empirical study beyond current therapeutic funding trends.
Key Arguments: Medical approval is the safest near-term path for psychedelics because it allows screening, set/setting control, and institutional oversight. State and local decriminalization may outpace scientific and cultural readiness, risking harm and federal legal conflict. The main psychedelic risk is not just a bad trip but acute psychiatric destabilization in vulnerable people, especially mania or psychosis. Causal links to schizophrenia are hard to prove, but enough case reports and observed mania episodes justify a conservative approach and exclusion criteria. Psychedelics and meditation are different but deeply complementary methods for exploring the nature of mind and reducing attachment to thought and narrative. Psilocybin can produce enduring changes in well-being and prosocial behavior, especially when paired with meditation practices. The broader importance of psychedelics lies in their potential to cultivate interconnectedness, gratitude, and ethical insight in otherwise healthy people. Griffiths’s cancer diagnosis sharpened rather than diminished his sense of life’s preciousness and reinforced his commitment to conscious awareness. A durable, scientifically rigorous research institution is needed to study psychedelics and spirituality over decades, not just within therapeutic product cycles.
Data Points: Years since prior conversation: Almost exactly 3 years - Sam Harris notes the previous interview and reflects on what has changed since then. Griffiths publication count: Over 400 scientific publications - Introduced in the episode description as part of Griffiths’s background. Cancer diagnosis: Stage four - Griffiths discusses his untreatable cancer diagnosis and its impact on his outlook. Endowment goal: $20 million - Target for the Johns Hopkins professorship and research fund. Current pledged amount: $14 million - Griffiths says the campaign is close to closing a $6 million gap. Remaining funding gap: $6 million - Amount still needed to reach the endowment goal. Waking Up Foundation support: $250,000 over 2 years - Sam Harris announces his foundation’s contribution to the project. MDMA approval timeline estimate: 2 to 4 years - Griffiths’s best guess for MDMA approval for PTSD, subject to FDA review. Depression approval timeline estimate: 3 to 5 years - Griffiths estimates a slower path for psilocybin or related depression trials. Population prevalence of schizophrenia: About 1% - Used to illustrate why widespread psychedelic use could reveal rare adverse outcomes if causally linked. Meditation retreat microdose: About 10 micrograms of LSD - Sam Harris describes a microdose taken during a week-long retreat. Long-term meditation experience: Tens of thousands of hours - Griffiths references meditators in an unpublished psilocybin study. Follow-up duration in cancer study: Six months - Griffiths references early Hopkins cancer-patient psilocybin work with lasting effects through follow-up. Extended follow-up in another study: More than 5 years - He notes another study with long-term persistence of benefits. Time since diagnosis: 1 year - Griffiths says the diagnosis occurred about a year before the recording.
Pivotal Quotes: "The hallmark of this research shall be the scientific method." — Roland Griffiths: Quoted from the webpage describing the Johns Hopkins endowment project. "I really felt in some sense initially that I was in a psychedelic experience." — Roland Griffiths: Griffiths describing the altered quality of consciousness after his cancer diagnosis. "There's something fundamentally important about this project for us to understand the nature of these changes and then put them to good use." — Roland Griffiths: Griffiths explaining why psychedelic research matters beyond medical treatment.
Implications: The conversation points toward a future where psychedelics are integrated cautiously through rigorous science, careful screening, and cultural supports. It also reframes mortality and meaning as practical domains for research, not just philosophy.
About Making Sense with Sam Harris
Join neuroscientist, philosopher, and five-time New York Times best-selling author Sam Harris as he explores important and controversial questions about the mind, society, current events, moral philosophy, religion, and rationality—with an overarching focus on how a growing understanding of ourselves and the world is changing our sense of how we should live. Sam is also the creator of the Waking Up app. Combining Sam’s decades of mindfulness practice, profound wisdom from varied philosophical...